Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis

NCT00486798 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00486798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00486798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2007
Completion date
August 31, 2007
Enrollment
Not reported
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, psychotic disorders, schizophrenia